Aspects of the present disclosure relate to a spectacle lens that suppresses progression of abnormal refractions (e.g., ametropia) caused by myopia and hyperopia in human eyes.
Myopia, also known as near-sightedness and short-sightedness, is a condition of the eye where the light that comes in does not directly focus on the retina but in front of it, causing the image that one sees when looking at a distant object to be out of focus, but in focus when looking at a close object.
Myopia is most commonly corrected through the use of corrective lenses, such as glasses or contact lenses. It may also be corrected by refractive surgery, though there are cases of associated side effects. The corrective lenses have a negative optical power (i.e. have a net concave effect) which compensates for the excessive positive diopters of the myopic eye. Negative diopters are generally used to describe the severity of the myopia, as this is the value of the lens to correct the eye. High-degree myopia, or severe myopia, is defined as −6 diopters or worse.
Hyperopia is a condition of over-measured sight commonly known as being farsighted (American English) or longsighted (British English). Hyperopia is a defect of vision caused by an imperfection in the eye when the eyeball is too short or the lens cannot become round enough. This defect causes difficulty in focusing on near objects, and in extreme cases causing a sufferer to be unable to focus on objects at any distance. As an object moves toward the eye, the eye must increase its optical power to keep the image in focus on the retina. If the power of the cornea and lens is insufficient, as in hyperopia, the image will appear blurred.
People with hyperopia can experience blurred vision, asthenopia, accommodative dysfunction, binocular dysfunction, amblyopia, and strabismus, another condition that frequently causes blurry near vision. Presbyopes who report good far vision typically experience blurry near vision because of a reduced accommodative amplitude brought about by natural aging changes with the crystalline lens. It is also sometimes referred to as farsightedness, since in otherwise normally-sighted persons it makes it more difficult to focus on near objects than on far objects.
The causes of hyperopia are typically genetic and involve an eye that is too short or a cornea that is too flat, so that images focus at a point behind the retina.
Aspects of the disclosure include a spectacle lens
(1) A spectacle lens including:
a first refraction area having a first refractive power based on a prescription for correcting an abnormal refraction (e.g., ametropia) of an eye; and
second refraction areas having a refractive power different from the first refractive power, and having a function of focusing an image on a position other than a retina of the eye so as to suppress a progress of the abnormal refraction (e.g., ametropia) of the eye,
wherein the second refraction areas are formed as a plurality of respectively independent island-shaped areas in the vicinity of a center part of a lens, and
the first refraction area is formed as the area other than the areas formed as the second refraction areas.
(2) The spectacle lens according to (1), wherein the spectacle lens is the spectacle lens having a function of suppressing a progress of myopia, and the second refraction areas have a refractive power obtained by adding a positive refractive power to the first refractive power.
(3) The spectacle lens according to (1), wherein the spectacle lens is the spectacle lens having a function of suppressing a progress of hyperopia, and the second refraction areas have a refractive power obtained by adding a negative refractive power to the first refractive power.
(4) The spectacle lens according to any one of (1) to (3), wherein the area of each independent island-shaped second refraction area is 0.50 to 3.14 mm2.
(5) The spectacle lens according to any one of (1) to (4), wherein the second refraction areas are formed in a circle area having a radius of 20 mm, with an optical center of the spectacle lens as a center.
(6) The spectacle lens according to any one of (1) to (5), wherein the second refraction areas are not formed in the circle area having a radius of 2.5 to 10.0 mm, with an optical center of the spectacle lens as a center.
(7) The spectacle lens according to any one of (1) to (6), wherein a ratio of total area of the second refraction areas, with respect to the total areas of the second refraction areas and the first refraction area, is 20 to 60% in an area formed by a mixture of the second refraction areas and the first refraction area.
(8) The spectacle lens according to any one of (1) to (3), wherein the second refraction areas are formed into circular shapes.
(9) The spectacle lens according to (4), wherein a diameter of each circular-shaped circle is 0.8 to 2.0 mm.
(10) The spectacle lens according to any one of (1) to (9), wherein the refractive power of the second refraction areas is differentiated from the refractive power of the first refraction area by differentiating surface shapes of the second refraction areas from a surface shape of the first refraction area.
(11) The spectacle lens according to (10), wherein the surface shapes of the second refraction areas are formed into convex or concave shapes toward an object side, with respect to the surface shape of the first refraction area.
(12) The spectacle lens according to any one of (1) to (9), wherein the second refraction areas have the refractive power different from the refractive power of the first refraction area by being made of a material different from the material of the first refraction area.
A lens described in Japanese Patent Publication No. 4891249 is known as the lens having the function of suppressing the progress of the abnormal refractions (e.g., ametropia) of myopia and hyperopia in human eyes.
The lens described is a concentric Fresnel multifocus lens. Namely, this lens is the lens in which a plurality of refraction areas are concentrically arranged, wherein at least one of these refraction areas as a first refraction area has a first refractive power based on a prescription for correcting the abnormal refraction (e.g., ametropia) of eyes. Then, the refraction areas other than the first refraction area respectively have at least one refractive power different from the first refractive power.
The refraction areas other than the first refraction area may be second refraction areas only having a second refractive power different from the first refractive power, or may be a plurality of refraction areas having a plurality of refractive powers different from each other, like third refraction areas having a third refractive power, and fourth refraction areas having a fourth refractive power, . . . other than the second refraction areas.
Then, in the above-mentioned lens, the areas having the first refractive power have a function of focusing an image on a retina of an eye. Meanwhile, for example, when constituting the lens for suppressing the progress of myopia, the refraction areas other than the refraction areas having the first refractive power, are formed of a material having the function of focusing the image on a point in front of the retina of the eye. Thus, if a patient uses the lens for suppressing myopia for viewing an object, an image of the object is formed on the retina while an image is formed on the point in front of the retina. Thus, an action of suppressing the progress of myopia can be obtained by the image formed in front of the retina by the refractive power other than the first refractive power, while visually recognizing the image of the object formed by the first refractive power.
Incidentally, the above-mentioned conventional lens is a so-called concentric Fresnel multifocus lens. Such a concentric multifocus lens has almost no problem when being applied to a case that the lens moves together with eyes like a contact lens and there is almost no change of a relative positional relation between the eyes and the lens.
However, when the concentric Fresnel multifocus lens is applied to a spectacle lens, there is no problem if an object is viewed by a visual line passing through a center of a lens. However, when a visual line passes through a position away from the center of the lens, an image of one object is formed in such a way that the image formed by the first refraction area and the image formed by the second refraction areas are viewed in a different direction respectively, resulting in viewing the object doubly, and it is difficult to use such a lens as the spectacle lens.
An aspect of the present disclosure is to provide a spectacle lens capable of exhibiting a function of suppressing the progress of the abnormal refraction (e.g., ametropia) of the eye while securing a sufficient visibility and an excellent wearing feeling.
In the above-mentioned structure, generally the first refraction area has the function of focusing the image on the retina of the eye. However, for example in a case of forming the lens of suppressing the progress of myopia, the second refraction areas are made of the material having the function of focusing the image on the point in front of the retina of the eye. Thus, when the patient uses the lens of suppressing the progress of myopia for viewing the object, an image of the object is formed on the retina while an image is formed in front of the retina. Namely, this lens has an action of suppressing the progress of myopia by the image in front of the retina, which is the action obtained by the refractive power other than the first refractive power, while visually recognizing the image of the object formed by the first refractive power. The same thing can be said for a case of hyperopia except for the following matter: the image is focused on a backside of the retina of the eye by the second refraction areas in the case of hyperopia.
Here, the second refraction areas are formed as a plurality of respectively independent island-shaped areas in the vicinity of the center part of the lens, wherein the first refraction area is formed as the area other than the areas formed as the second refraction areas.
Namely,
a. the second refraction areas are formed in the vicinity of the center part,
b. the second refraction areas are formed as a plurality of independent island-shaped areas, and
c. the area other than the areas formed as the second refraction areas, is the first refraction area, to obtain the following effects.
d. In a state of viewing frontward, the visual line passes through the approximate center part of the lens for viewing the object, and therefore the object is viewed by a light beam passing through the plurality of second refraction areas arranged dispersedly so as to be included in the first refraction area, and a light beam passing through the first refraction area. As a result, this lens has the action of suppressing the progress of myopia by the image formed in front of the retina by the second refractive power, while visually recognizing the image of the object formed by the first refractive power.
e. When the eye moves, the visual line is deviated from the center part and passes through a peripheral part. However, the peripheral part is an area having the refractive power based on a prescription (i.e. an area having the first refractive power), and therefore the object can be excellently recognized. A wearer feels almost no discomfort even if the eye moves. Therefore, the function of suppressing the progress of the abnormal refraction (e.g., ametropia) of the eye can be exhibited, while securing a sufficient visibility and an excellent wearing feeling.
As shown in
As shown in cross-sectional views of
Each surface of the second refraction areas 2 formed as a plurality of island-shaped areas has an area of about 0.50 to 3.14 mm2, and has a circular shape having a diameter d of about 0.8 to 2.0 mm. The plurality of island-shaped second refraction areas 2 are approximately evenly arranged in the vicinity of the center of the lens in a way to be separated from each other by a distance almost equal to a value of a radius d/2.
The plurality of island-shaped second refraction areas 2 are formed in a way to be included in a circular area having a radius R (20 mm or less) with an optical center O as a center of the lens, and are arranged in a way to form a hexagon inscribed in a circle having a radius R for example. Here, the second refraction areas 2 are not arranged as circular areas having a radius 2.5 to 10.0 mm with the optical center O of the spectacle lens as the center. Then, a ratio of total area of the second refraction areas, with respect to the total areas of the second refraction areas and the first refraction area, is 20 to 60% in an area formed by a mixture of the second refraction areas and the first refraction. Thus, a sufficient visibility can be maintained and an excellent wearing feeling can be obtained, while securing the function of suppressing the progress of myopia.
The above-mentioned embodiment shows the example in which the refraction areas other than the first refraction area are formed as the second refraction areas only having the second refractive power different from the first refractive power. However, these refraction areas may be a plurality of refraction areas respectively having a plurality of refractive powers different from each other, like the third refraction areas having the third refractive power, and the fourth refraction areas having the fourth refractive power . . . . In this case, this plurality of refraction areas are suitably dispersed in the area in which the above-mentioned second refraction areas are configured.
This application is a continuation of U.S. application Ser. No. 14/935,322, filed Nov. 6, 2015, granted as U.S. Pat. No. 10,268,050 on Apr. 23, 2019, and the contents of which is incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
3628854 | Jampolsky | Dec 1971 | A |
3794414 | Wesley | Feb 1974 | A |
3902693 | Crandon et al. | Sep 1975 | A |
4704016 | De Carle | Nov 1987 | A |
4989967 | Matsuda | Feb 1991 | A |
5044742 | Cohen | Sep 1991 | A |
5359440 | Hamada et al. | Oct 1994 | A |
5507806 | Blake | Apr 1996 | A |
5585968 | Guhman et al. | Dec 1996 | A |
5753092 | Hollars et al. | May 1998 | A |
5786883 | Miller et al. | Jul 1998 | A |
5798027 | Lefebvre et al. | Aug 1998 | A |
6129042 | Smith et al. | Oct 2000 | A |
6258218 | Burton | Jul 2001 | B1 |
7164571 | Wickramanayaka et al. | Jan 2007 | B2 |
7766478 | Phillips | Aug 2010 | B2 |
8206562 | Walls et al. | Jun 2012 | B2 |
8684520 | Lindacher et al. | Apr 2014 | B2 |
9411172 | Haddock et al. | Aug 2016 | B2 |
10014163 | Waugh et al. | Jul 2018 | B2 |
20020023837 | Stimson | Feb 2002 | A1 |
20020145797 | Sales | Oct 2002 | A1 |
20030081172 | Dreher | May 2003 | A1 |
20030210466 | Huang | Nov 2003 | A1 |
20050056125 | Trumper | Mar 2005 | A1 |
20060188660 | Teer | Aug 2006 | A1 |
20060274267 | Miller et al. | Dec 2006 | A1 |
20070002453 | Munro | Jan 2007 | A1 |
20070247588 | Cano et al. | Oct 2007 | A1 |
20080164147 | Dogi et al. | Jul 2008 | A1 |
20080223715 | Gibson et al. | Sep 2008 | A1 |
20080254210 | Lai et al. | Oct 2008 | A1 |
20080286458 | Kirchoff | Nov 2008 | A1 |
20090006017 | Young et al. | Jan 2009 | A1 |
20090153795 | Blum et al. | Jun 2009 | A1 |
20090225435 | Boettiger et al. | Sep 2009 | A1 |
20090268154 | Meyers et al. | Oct 2009 | A1 |
20100183900 | Wallin et al. | Jul 2010 | A1 |
20100201941 | Gupta et al. | Aug 2010 | A1 |
20110051079 | Martinez et al. | Mar 2011 | A1 |
20110313058 | Neitz et al. | Dec 2011 | A1 |
20120033120 | Nakamura et al. | Feb 2012 | A1 |
20120062836 | Tse et al. | Mar 2012 | A1 |
20120097528 | Teer et al. | Apr 2012 | A1 |
20130033636 | Pitts et al. | Feb 2013 | A1 |
20130069258 | Ballet et al. | Mar 2013 | A1 |
20140016015 | Miao | Jan 2014 | A1 |
20140055743 | Okubo et al. | Feb 2014 | A1 |
20140116986 | Akasaka | May 2014 | A1 |
20140211147 | Wei et al. | Jul 2014 | A1 |
20140327875 | Blum et al. | Nov 2014 | A1 |
20140347622 | Wu | Nov 2014 | A1 |
20150109574 | Tse et al. | Apr 2015 | A1 |
20150124212 | Loertscher et al. | May 2015 | A1 |
20150160477 | Dai | Jun 2015 | A1 |
20150247960 | Kildishev et al. | Sep 2015 | A1 |
20150309332 | Hillenbrand et al. | Oct 2015 | A1 |
20160026000 | Kester | Jan 2016 | A1 |
20160377884 | Lau et al. | Dec 2016 | A1 |
20170184875 | Newman | Jun 2017 | A1 |
Number | Date | Country |
---|---|---|
101713871 | May 2010 | CN |
102692730 | Sep 2012 | CN |
104678572 | Jun 2015 | CN |
201211618 | Mar 2012 | TW |
2009100257 | Aug 2009 | WO |
2012138426 | Oct 2012 | WO |
2015147758 | Oct 2015 | WO |
2016107919 | Jul 2016 | WO |
Entry |
---|
First Office Action dated Aug. 3, 2017 by the State Intellectual Property Office of the People's Republic of China for Patent Application No. 201310628174.8, which was filed on Nov. 29, 2013 and published as CN104678572 on Jun. 3, 2015 (Inventor-Hatanaka et al.,; Applicant—Hoya Lens Thailand Ltd.) (Original: 10 pages // Translation: 15 pages). |
U.S. Appl. No. 14/935,322, “Advisory Action”, dated Oct. 31, 2018, 3 pages. |
U.S. Appl. No. 14/935,322, “Final Office Action”, dated May 18, 2018, 19 pages. |
U.S. Appl. No. 14/935,322, “Non-Final Office Action”, dated Sep. 26, 2017, 17 pages. |
U.S. Appl. No. 14/935,322, “Notice of Allowance”, dated Nov. 29, 2018, 9 pages. |
U.S. Appl. No. 62/148,102 (Marshall et al.), filed Apr. 15, 2015. |
Number | Date | Country | |
---|---|---|---|
20190212580 A1 | Jul 2019 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14935322 | Nov 2015 | US |
Child | 16298917 | US |